Business Insider6d
Aardvark Therapeutics initiated with an Outperform at RBC Capital
RBC Capital analyst Brian Abrahams initiated coverage of Aardvark Therapeutics (AARD) with an Outperform rating and $21 price target Aardvark Therapeutics has a shot at establishing a key role for ...
Business Insider6d
Aardvark Therapeutics initiated with an Overweight at Cantor Fitzgerald
Cantor Fitzgerald initiated coverage of Aardvark Therapeutics (AARD) with an Overweight rating and $50 price target Aardvark is developing ARD-101, a gut-restricted drug in Phase 3 for Prader ...
Crass or cool, awesome or eyesore: Big 12 Tournament’s logo’d court makes a statement either way
The logo'd court at the Big 12 Tournament is causing quite a stir. It's cool or crass, awesome or an eyesore, depending on ...
Dallas Morning News5d
Crass or cool, awesome or eyesore: Big 12 Tournament’s logo’d court makes a statement either way
featuring black baselines and sidelines and the Big 12 logo splashed across center court. The product is cool or crass, awesome or ugly, depending on who you ask, yet there appeared to be precious ...
The Durango Herald5d
Crass or cool, awesome or eyesore: Big 12 Tournament's logo'd court makes a statement either way
The gray-hued floor actually debuted during last week's women's Big 12 Tournament, featuring black baselines and sidelines and the Big 12 logo splashed across center court. The product is cool or ...
U.S. News & World Report5d
Crass or Cool, Awesome or Eyesore: Big 12 Tournament's Logo'd Court Makes a Statement Either Way
Crass or Cool, Awesome or Eyesore: Big 12 Tournament's Logo'd Court Makes a Statement Either Way KANSAS CITY, Mo. (AP) — Big 12 commissioner Brett Yormark wanted the league's postseason ...
pharmaphorum2d
Aardvark said to be planning IPO, plus other bio financings
Our regular round-up of financings in the biotech sector is headed by rumours of a $150 to $200 million initial public offering (IPO) for Aardvark Therapeutics, an emerging player in the weight ...